Brain tumor senescence might be mediated by downregulation of S-phase kinase-associated protein 2 via butylidenephthalide leading to decreased cell viability
- 258 Downloads
Developing an effective drug for treating human glioblastoma multiform (GBM) has been investigated persistently. A pure compound butylidenephthalide (BP), isolated from Angelica sinensis, has been shown the activities to arrest the growth and initiate apoptosis of GBM in our previous reports. In this study, we further demonstrated that BP treatment accelerates the cell senescence in a dose-dependent manner in vitro and in vivo. S-phase kinase-associated protein 2 (Skp2), a proto-oncogene, is generally upregulated in cancer. We found that it was downregulated in BP-treated GBM cells. The downregulation of Skp2 is parallel with increasing p16 and p21 expression which causes G0/G1 arrest and tumor cell senescence. We also found that restoring the Skp2 protein level by exogenous overexpression prevents the BP-induced cell senescence. Therefore, the linkage between cell senescence and Skp2 expression is strengthened. Promoter binding analysis further detailed that the BP-mediated SP1 reduction might involve in the Skp2 downregulation. In summary, these results emphasize that BP-triggered senescence in GBM cells is highly associated with its control on Skp2 regulation.
KeywordS-phase associated kinase protein 2 Glioblastoma multiform Butylidenephthalide Senescence
S-phase kinase-associated protein 2
This work was supported by National Science Council of the Republic of China (NSC 102-2320-B-039-011), Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004); Aim for the Top University Plan of the National Chiao Tung University and Ministry of Education, Cancer Research Center of Excellence (Taiwan) and Ministry of Economic Affairs (102-EC-17-A-19-I1-0051).
Conflicts of interest
- 2.Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, Canoll P. Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses. J Neurosci Off J Soc Neurosci. 2006;26(25):6781–90. doi: 10.1523/JNEUROSCI.0514-06.2006.CrossRefGoogle Scholar
- 10.Tsai NM, Chen YL, Lee CC, Lin PC, Cheng YL, Chang WL, et al. The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo. J Neurochem. 2006;99(4):1251–62. doi: 10.1111/j.1471-4159.2006.04151.x.CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol. 2005;25(24):10875–94. doi: 10.1128/MCB.25.24.10875-10894.2005.CrossRefPubMedPubMedCentralGoogle Scholar